Lawrence J. Jasinski - Dec 9, 2024 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Director
Signature
/s/ John Pitfield
Stock symbol
LMAT
Transactions as of
Dec 9, 2024
Transactions value $
$0
Form type
4
Date filed
12/11/2024, 09:17 PM
Previous filing
Dec 10, 2024
Next filing
Dec 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $0 +1 +0.02% $0.00 5.53K Dec 9, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -1 -24.94% $0.00 3.01 Dec 9, 2024 Common Stock 1 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.